Kai Blin
- Pharmacology top 0.02%
- Microbial Natural Products and Biosynthesis 35
- Biotechnology top 0.05%
- Marine Sponges and Natural Products 4
- Microbiology top 0.5%
- Molecular Biology top 0.5%
- Genomics and Phylogenetic Studies 22
- Plant biochemistry and biosynthesis 10
- RNA and protein synthesis mechanisms 7
- CRISPR and Genetic Engineering 6
- Microbial Metabolic Engineering and Bioproduction 5
- Ecology top 0.5%
-
- Computational Drug Discovery Methods 5
- Co-authors
- Tilmann WeberMarnix H. MedemaSimon J. ShawSang Yup LeeEriko TakanoRainer BreitlingMichael A. FischbachGilles P. van Wezel
- Journals
- Nucleic Acids Research (22 papers)Synthetic and Systems Biotechnology (4 papers)ACS Chemical Biology (2 papers)
- Partner nations
- DenmarkGermanyNetherlands
In The Last Decade
Kai Blin
43 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Pharmacology 5.9k
- Biotechnology 2.2k
- Microbiology 144
- Molecular Biology 8.6k
- Ecology 2.0k
Countries citing papers authored by Kai Blin
This map shows the geographic impact of Kai Blin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Blin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Blin more than expected).
Fields of papers citing papers by Kai Blin
This network shows the impact of papers produced by Kai Blin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Blin. The network helps show where Kai Blin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kai Blin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 13 | |
| 3 | antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisationbreakdown → | 2023 | 1116 |
| 4 | 2022 | 9 | |
| 5 | 2020 | 101 | |
| 6 | 2020 | 146 | |
| 7 | 2020 | 19 | |
| 8 | 2020 | 38 | |
| 9 | 2020 | 20 | |
| 10 | 2019 | 137 | |
| 11 | 2017 | 326 | |
| 12 | 2017 | 141 | |
| 13 | 2017 | 225 | |
| 14 | 2017 | 25 | |
| 15 | antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identificationbreakdown → | 2017 | 920 |
| 16 | 2016 | 175 | |
| 17 | 2014 | 39 | |
| 18 | antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producersbreakdown → | 2013 | 645 |
| 19 | antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequencesbreakdown → | 2011 | 1481 |
| 20 | NRPSpredictor2—a web server for predicting NRPS adenylation domain specificitybreakdown → | 2011 | 487 |
About Kai Blin
Kai Blin is a scholar working on Pharmacology, Biotechnology, Molecular Biology, Business and International Management and Molecular Medicine, having authored 46 papers that have together received 12.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (35 papers), Genomics and Phylogenetic Studies (22 papers), Plant biochemistry and biosynthesis (10 papers), RNA and protein synthesis mechanisms (7 papers), CRISPR and Genetic Engineering (6 papers), Computational Drug Discovery Methods (5 papers), Microbial Metabolic Engineering and Bioproduction (5 papers) and Marine Sponges and Natural Products (4 papers). The work is most often cited by research in Pharmacology (5.9k citations), Biotechnology (2.2k citations), Microbiology (144 citations), Molecular Biology (8.6k citations) and Ecology (2.0k citations). Kai Blin has collaborated with scholars based in Denmark, Germany and Netherlands. Frequent co-authors include Tilmann Weber, Marnix H. Medema, Simon J. Shaw, Sang Yup Lee, Eriko Takano, Rainer Breitling, Michael A. Fischbach, Gilles P. van Wezel, Nadine Ziemert and Kat Steinke. Their work appears in journals such as Nucleic Acids Research, Synthetic and Systems Biotechnology, ACS Chemical Biology, Briefings in Bioinformatics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.